Omega-3 fatty acids may inhibit prostate cancer cell growth
the ONA take:
In contradiction to a 2013 study, researchers have found a mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells. The new study was published in the Journal of Pharmacology and Experimental Therapeutics.
Kathryn Meier, PhD, and two students at Washington State University looked at prostate cell cultures and found that fatty acids are able to bind to FFA4, the “free fatty acid receptor 4”, which inhibits growth factors and suppresses the spread of cancer cells.
“This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works,” Dr. Meier said.
This study contrasts with a 2013 study published in the Journal of the National Cancer Institute which found that men with higher levels of omega-3 fatty acids in their blood had a greater risk of developing prostate cancer.
However, it is still unclear if the effect can be obtained through dietary supplements, and that the drug needs to be in a cancer cell constantly in order to take effect.
A mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|